Melhem Solh

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse
    Melhem Solh
    Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, 55455, USA
    Biol Blood Marrow Transplant 18:106-12. 2012
  2. ncbi Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients
    Melhem Solh
    Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA
    Transplantation 91:798-803. 2011
  3. ncbi A prognostic index for survival among mechanically ventilated hematopoietic cell transplant recipients
    Melhem Solh
    Blood and Marrow Transplant Program, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Biol Blood Marrow Transplant 18:1378-84. 2012
  4. ncbi Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants
    Melhem Solh
    Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Biol Blood Marrow Transplant 17:710-6. 2011

Detail Information

Publications4

  1. ncbi Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse
    Melhem Solh
    Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, 55455, USA
    Biol Blood Marrow Transplant 18:106-12. 2012
    ..GVHD and its accompanying graft-versus-leukemia effect may better protect BM sites, but patients with EM relapse have better responses to combined therapy and improved survival compared with those with BM relapse...
  2. ncbi Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients
    Melhem Solh
    Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA
    Transplantation 91:798-803. 2011
    ..We hereby present a study evaluating the incidence, risk factors, and outcomes of LONIPC in a recent cohort of allogeneic HCT recipients...
  3. ncbi A prognostic index for survival among mechanically ventilated hematopoietic cell transplant recipients
    Melhem Solh
    Blood and Marrow Transplant Program, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Biol Blood Marrow Transplant 18:1378-84. 2012
    ..Corresponding OS in class B patients was 5% and 15%, respectively. This prognostic index should help guide physicians in counseling HCT patients and their families regarding the use of MV and potential outcomes...
  4. ncbi Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants
    Melhem Solh
    Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Biol Blood Marrow Transplant 17:710-6. 2011
    ..Enhanced approaches to accelerate multilineage engraftment could limit the transfusion-associated morbidity and costs accompanying UCB allotransplantation...